Voriconazole Tablets
Form: Tablets
Strength: 50 mg, 200 mg
Reference Brands: Vfend(US & EU)
Category: Anti-fungal
Voriconazole tablets are approved in the EU and US for treating invasive fungal infections. In the EU, Pfizer’s Vfend is regulated by EMA, supported by dossiers demonstrating safety, efficacy, and quality. In the US, FDA approval is based on comprehensive clinical data, biosimilarity, and pharmacovigilance. Both regions require detailed dossiers for initial authorization and ongoing safety monitoring. For expert assistance with pharmaceutical dossiers, regulatory submissions, and compliance, visit PharmaTradz, your trusted partner in regulatory solutions. We help ensure smooth market access and adherence to European and American standards for voriconazole tablets, supporting your product’s global success.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Nystatin Oral Suspensions/Tablets
Strength: Tab: 500,000 units, 1,000,000 units; Sus: 100,000 units/mL, 500,000 units/5 mL
Form: Tablets/Suspensions
Reference Brands: Mycostatin, Nilstat, Nystop(US)
View Details Get Enquiry
Nystatin Topical Creams and Ointments
Strength: 100,000 units/g, 100,000–300,000 units/g
Form: Topical Creams and Ointments
Reference Brands: Mycostatin, Nilstat, Nystop(US)
View Details Get Enquiry
Micafungin Intravenous (IV) Powder
Strength: 50 mg, 100 mg/vial
Form: Intravenous (IV) Powder
Reference Brands: Mycamine(US & EU)
View Details Get Enquiry
Anidulafungin injection
Strength: 50 mg/vial
Form: Intravenous (IV) Powder
Reference Brands: Eraxis(US)
View Details Get Enquiry